Cargando…
Artificial Macrocycles as Potent p53–MDM2 Inhibitors
[Image: see text] Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53–MDM2 interaction was designed and synthesized. These macrocycles, alternatively to stapled peptides, target for the first time the...
Autores principales: | Estrada-Ortiz, Natalia, Neochoritis, Constantinos G., Twarda-Clapa, Aleksandra, Musielak, Bogdan, Holak, Tad A., Dömling, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641952/ https://www.ncbi.nlm.nih.gov/pubmed/29057045 http://dx.doi.org/10.1021/acsmedchemlett.7b00219 |
Ejemplares similares
-
Optimized Inhibitors of MDM2 via an Attempted Protein‐Templated Reductive Amination
por: van der Vlag, Ramon, et al.
Publicado: (2019) -
Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists
por: Neochoritis, Constantinos G, et al.
Publicado: (2019) -
Discovery of Highly Potent p53-MDM2 Antagonists and
Structural Basis for Anti-Acute Myeloid Leukemia Activities
por: Huang, Yijun, et al.
Publicado: (2014) -
Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
por: Zyla, Edyta, et al.
Publicado: (2021) -
Fragment-Based Library
Generation for the Discovery
of a Peptidomimetic p53-Mdm4 Inhibitor
por: Boltjes, André, et al.
Publicado: (2014)